Part, Chapter, Paragraph
1 II, 4. 1 | currently around 70, while females had 75 and 78 respectively.
2 II, 5. 5. 1| 1:9 for males, 1:42 for females) (Schmidtke et al, 2004).~ ~
3 II, 5. 5. 1| 15-64 and 65+ age groups, females in all countries have much
4 II, 5. 5. 3| common in adolescents and females (Levey, 2006). Levey (2006)
5 II, 5. 5. 3| increase among 15-24-year-old females was noticed from 1935 to
6 II, 5. 5. 3| increase among 15-24-year-old females was noticed from 1935 to
7 II, 5. 5. 3| rate among 10-14-year-old females has risen since the 1950s
8 II, 5. 5. 3| prevalence rate of 0.3% for young females in Western Europe and the
9 II, 5. 5. 3| is 1% for 15-24-year-old females. 0.1% of young men are bulimic
10 II, 5. 5. 3| bulimia affects 30 per 100.000 females, whereby the incidence rate
11 II, 5. 5. 3| group (i.e., 20–24-year-old females) shows an incidence rate
12 II, 5. 5. 3| for males and 579006 for females (Mathers et al, 2006).~Deficits
13 II, 5. 5. 3| disorder which affects mostly females and usually develops between
14 II, 5. 5. 3| studies, the dominance in females and males has been found
15 II, 5. 6. 3| OA is more common in females, increasing at the age of
16 II, 5. 6. 3| impairment, particularly among females.~ ~OA was estimated to be
17 II, 5. 6. 3| 36 per 100,000 for adult females. Estimates of the prevalence
18 II, 5. 7. 3| higher in males than in females (Table 5.7.3). Whereas incidence
19 II, 5. 7. 3| countries and more frequent in females than in males. The higher
20 II, 5. 7. 3| higher prevalence on CKD in females, which flies in the face
21 II, 5. 7. 3| et al, 1999), is lower in females than in males. Furthermore,
22 II, 5. 7. 3| Viktorsdottir et al, 2005) in females (Figure 5.7.3), while higher
23 II, 5. 7. 3| either similar in males and females (Germany, Italy) or higher
24 II, 5. 7. 3| Germany, Italy) or higher in females (Belgium (Van Biesen et
25 II, 5. 7. 3| higher in males compared to females (Table 5.7.7). Prevalence
26 II, 5. 7. 3| countries and more frequent in females than in males. The higher
27 II, 5. 7. 3| higher prevalence on CKD in females, which flies in the face
28 II, 5. 7. 3| et al, 1999), is lower in females than in males. Furthermore,
29 II, 5. 8. 3| 40% in males and 140% in females between 1994 and 2015 (Feenstra
30 II, 5. 8. 3| in males and by 90% in females (from 1.0 to 2.9 per 1 000)
31 II, 5. 8. 3| 3, 0.4, respectively, in females.~ ~Mortality.~ ~Although
32 II, 5. 8. 3| fat-free mass index (FFMI) <15 (females) or <16 (males) kg/m2) in
33 II, 5. 9. 3| puberty, in particular in females, and is characterized by
34 II, 5. 9. 4| the onset of puberty in females an unlikely contributory
35 II, 5. 9. 4| symptomatic males but not in females may be in part responsible
36 II, 5. 9. 4| expression of asthma and atopy in females may also be implicated (
37 II, 5. 9. 4| an incidence higher among females (2.9 cases.1000 person-yrs(-
38 II, 5. 9. 4| in males (35.7%) than in females (28.8%). Skin sensitization
39 II, 5. 9. 4| the males and 8.0% of the females (P=0.03). Analysis by multiple
40 II, 5. 11. 3| differences in prevalence between females and males correlates with
41 II, 5. 11. 3| nickel allergy among young females with pierced skin has varied
42 II, 7. 3. 2| injuries affect males and females disproportionately. The
43 II, 7. 3. 2| 000 males) than it is for females (35 per 100 000 females).
44 II, 7. 3. 2| females (35 per 100 000 females). As a result, 66% of EU
45 II, 8. 2. 3| Sweden (Odds Ratios males/females in the range 0.9-1.2), with
46 II, 8. 2. 3| in men (Odd Ratios males/females in the range 1.5-2.3). Prevalence
47 II, 8. 2. 3| be 3.3% (males) and 2.8% (females) in the WHO EUR-A epidemiological
48 II, 8. 2. 3| males) and 4.3 YLD/1000 (females) in the WHO EURO A and to
49 II, 8. 2. 3| 3.3 YLD/1000 (males and females) in the WHO EURO B1 (WHO,
50 II, 9. 3. 1| identified between males and females (Wizemann & Pardue, 2001)
51 II, 9. 3. 1| times higher than that of females (Niederlaender, 2006). This
52 II, 9. 3. 1| are consistently lower for females across the lifespan, while
53 II, 9. 3. 1| and the Czech Republic for females. Mortalities in the recent
54 II, 9. 3. 1| third of cases (36%) were females. For biological and social
55 II, 9. 3. 3| but more among males than females. Risk reduction strategies
56 II, 9. 3. 3| of age for both males and females (Weiss, 2008).~ ~ ~All over
57 II, 9. 4. 3| during the 4th decade in females and in the 6th decade in
58 II, 9. 5. 1| the European average for females, while in Latvia it is ten
59 II, 9. 5. 3| developmental disorder~Males > > Females~Attention deficient hyperactivity
60 II, 9. 5. 3| disorder (ADHD)~Males > > Females~Conduct disorders~Males > >
61 II, 9. 5. 3| Conduct disorders~Males > > Females~Learning disability~Males > >
62 II, 9. 5. 3| Learning disability~Males > > Females~Adolescence~Depression~Females > >
63 II, 9. 5. 3| Females~Adolescence~Depression~Females > > Males~Deliberate self-harm~
64 II, 9. 5. 3| Males~Deliberate self-harm~Females > Males~Eating disorders~
65 II, 9. 5. 3| Males~Eating disorders~Females > > Males~Substance abuse~
66 II, 9. 5. 3| Substance abuse~Males > > Females~Adulthood~Depression and
67 II, 9. 5. 3| Adulthood~Depression and anxiety~Females > Males~Schizophrenia~Males =
68 II, 9. 5. 3| Males~Schizophrenia~Males = Females~Bipolar disorder~Males =
69 II, 9. 5. 3| Bipolar disorder~Males = Females~Substance abuse~Males > >
70 II, 9. 5. 3| Substance abuse~Males > > Females~Old agea~Dementias~Females >
71 II, 9. 5. 3| Females~Old agea~Dementias~Females > Males~Depression~Females >
72 II, 9. 5. 3| Females > Males~Depression~Females > Males~Psychoses~Females > >
73 II, 9. 5. 3| Females > Males~Psychoses~Females > > Males~> prevalence is
74 II, 9. 5. 3| Percentage of 25-64 year old females with at least upper secondary
75 II, 9. 5. 3| shown that in the UK young females are most likely to drink
76 II, 9. 5. 3| nutrients. Poor nutrition in females can reduce learning and
77 III, 10. 2. 1| declining for both males and females. In Eastern Europe, mortality
78 III, 10. 2. 1| while still increasing among females.~ ~Cigarette smoking harms
79 III, 10. 2. 1| Reduced fertility in males and females~- Earlier onset of menopause~-
80 III, 10. 2. 1| prevalence among males than females, especially when considering
81 III, 10. 2. 1| and 10-50 times higher for females, than that of the general
82 III, 10. 2. 1| well-being and body image of females: predictors of greatest
83 III, 10. 3. 4| amounting to 92% of all deaths. Females were particularly affected.
84 III, 10. 5. 2| rates in urban areas. For females, there is a similar trend
85 III, 10. 5. 2| an increased mortality in females irrespective of the settlement
86 III, 10. 5. 2| categories for males and females.~ ~Figure 10.5.2.5. Correlation
87 III, 10. 5. 2| urban and rural settlements, females~ ~One of the few national
88 III, 10. 5. 2| 2006). However, for rural females less problems were noticed
89 III, 10. 6. 1| individual social networks. Females tend to have stronger social
90 III, 10. 6. 3| were much lower than from females. On average, 0.5% of male
91 IV, 13. 2. 2| for males, and 579 006 for females, respectively. Mild mental
92 Key, Ap5. 0. 0| feeling~feelings~female~females~fertility~fetus~fetuses~
